Intellomx have received Chinese government approval for a novel clinical diagnostics study for TB, to distinguish patients with latent TB using biomarkers. We believe that our collaboration on a novel ...
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback